Allient's fiscal second quarter arrived with the company coming off a year-long transformation program and the shares in the middle of a remarkable run - up nearly threefold from an October low, closing at a fresh 52-week high in the week the quarter was reported. The operational news this quarter justified a good deal of that enthusiasm. Revenue rose 10% to $153.8 million, and that growth was clean: organic revenue rose 9.3%, with volume doing essentially all of the work and currency adding less than a point. Gross margin hit a record 34.9%, up from 33.2% a year ago, and with selling costs and interest both better controlled, operating income rose a third to $15.6 million and net income jumped 85% to $10.4 million. Management also reported a step-change in demand: bookings rose 49% to $201 million, lifting backlog 26% to $298 million - a book-to-bill well above one.
There are two ways to read the quarter, and they point in the same direction but with different urgency on the clock. The first is that the Simplify to Accelerate NOW restructuring, launched in 2024, is finally showing up where it matters: higher gross margin, lower interest expense on less debt, and earnings compounding faster than the top line. Adjusted earnings per share rose 40% to $0.80 on a GAAP $0.61. The second read is more cautious and just as important: the stock, at roughly $114 and a market capitalization near $1.9 billion, trades at something like 67 times trailing GAAP earnings and north of 35 times forward earnings - a premium reserved for a company whose acceleration is already here. The quarter answered whether the turnaround is real. It did. Whether the multiple has already priced the rest of it is the open question, and that is decided by execution in the second half, not by this report. The leading indicators - bookings, backlog, and gross margin - are flashing strength; revenue lags them, and cash flow ran behind earnings this half.